Article Correctness Is Author's Responsibility: Seeking better treatment for ALS, Lou Gehrig’s disease

In neurodegenerative disease ALS, proteins called TDP-43 aggregate in patient tissues. A team led by researchers at Cold Spring Harbor Laboratory found that in ALS, TDP-43 proteins are dysfunctional, causing de-silencing of retrotransposons or 'jumping genes.'